Association of Dialysis Adequacy, Physical and Emotional Symptoms with Erythropoietin-stimulating agent Responsiveness in Iraqi Patients Undergoing Hemodialysis
Background: Erythropoietin (EPO)-deficient anemia occurs in patients with chronic kidney disease (CKD). Erythropoietin-stimulating agents (ESAs) are the standard treatment for CKD anemia, but patient responses vary. Hemodialysis patients are often anemic due to hypo erythropoiesis and their chron...
Main Authors: | Salar Ahmed, Mohammed Mahmood, Arif Sami, Salim Hamadi |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Pharmacy / Mustansiriyah University
2024-01-01
|
Series: | Al-Mustansiriyah Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/1038 |
Similar Items
-
Investigation of Hemodialysis Adequacy in Patients Undergoing Hemodialysis in the Shohada Hospital in Bushehr
by: Zinab Ghorbane Moghaddam, et al.
Published: (2016-01-01) -
Comparative effectiveness of erythropoietin alpha and beta in hemodialysis patients: a single-center prospective observational study
by: Muhammad Nadeem Ahsan, et al.
Published: (2021-11-01) -
"Comparison Between Delivered (KT/V) And Hemodialysis Product In Dialysis Adequacy "
by: O. Taziki, et al.
Published: (2006-05-01) -
“Ideal” parathyroid hormone in erythropoietin‐stimulating agents‐resistant anemia
by: Bilal Ashraf, et al.
Published: (2022-02-01) -
Dialysis adequacy of chronic hemodialysis patients in Zanjan-Iran, 2016
by: Yosefi Kh, et al.
Published: (2017-06-01)